An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data

IgA Nephropathy Clinical Trial

Official title:

An Observational Study of the Relationship Between Pathological Variants and Clinical Data at Presentation and Follow-up in IgA Nephropathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01502579
• Other study ID #: GGH201106
• Status: Completed
• Phase: N/A
• First received: December 29, 2011
• Last updated: August 27, 2013
• Start date: September 2011
• Est. completion date: August 2013

Study information

• Verified date: August 2013
• Source: Guangdong General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The pathological variants of IgA nephropathy identified by the Oxford classification may be related to the clinical data at presentation and follow-up, including proteinuria and renal function. This study is aimed to identify the potential relationship between pathological variants and clinical data in IgA nephropathy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 603
• Est. completion date: August 2013
• Est. primary completion date: August 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• biopsy-proven IgA nephropathy;

Exclusion Criteria:

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Glomerulonephritis, IGA
• IgA Nephropathy
• Kidney Diseases

Locations

Country	Name	City	State
China	Guangdong General Hospital	Guangzhou	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Guangdong General Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	glomerular filtration rate decline or end-stage renal disease or doubling of serum creatinine		after the biopsy	No